|
 |
2010/04/20/ADDED SUGARS IN DIET THREATEN HEART HEALTH BUSINESSWEEK/
The page is no longer available. You may want to read the following pages.
J Fang, C Gillespie, NL Keenan... - Future Cardiology, 2011 - Future Medicine Coronary heart disease is the primary cause of death for both men and women in the USA, accounting
for one out of every five deaths [1]. In 2010, the American Heart Association estimated that there
will be 785,000 new heart attack events, and 470,000 recurrent attack events [2]. Previous ... [CITATION] TROPONIN T TESTING IN THE PREHOSPITAL DIAGNOSIS AND TRIAGE OF PATIENTS WITH SUSPECTED HEART ATTACKJT Sorensen, CJ Terkelsen, C Steengaard... - Journal of the American ..., 2011 - Elsevier
W Chung... - Progress in Pediatric Cardiology, 2011 - Elsevier Pediatric cardiomyopathies are extremely heterogeneous in etiology and are thus associated
with variability in prognosis and response to therapy. With increasing availability of clinical diagnostic
tools and research methods to molecularly characterize genetic forms of cardiomyopathy ...
SS Huang, H Placzek, J Livingston, A Ma... - Infection Control and ..., 2011 - JSTORObjective. To evaluate whether longitudinal insurer claims data allow reliable identification of elevated hospital surgical site infection (SSI) rates. Design. We conducted a retrospective cohort study of Medicare beneficiaries who underwent coronary artery bypass grafting ( ...
S Molhoek, J Bax, TH Marwick... - Congress of the ..., 2011 - , S., Bax, J., Marwick, TH, Van Erven, L., Steendijk, P., Van der Wall, E. and Schalij,
M. (2003). Tissue Doppler imaging to assess improvement in contractile function and resynchronization
after biventricular pacing in idiopathic cardiomyopathy patients. In: Frans Van de Werf, ...
FK Gould, DW Denning, TSJ Elliott... - Journal of ..., 2011 - Br Soc Antimicrob Chemo Abstract The BSAC guidelines on treatment of infectious endocarditis (IE) were last published in 2004. The guidelines presented here have been updated and extended to reflect developments in diagnostics, new trial data and the availability of new antibiotics. ...
|
|
|
